Kucukbay, HDurmaz, B2024-08-042024-08-0419970004-4172https://hdl.handle.net/11616/93073Forty organic or organometallic derivatives of benzimidazole and benzothiazole and five rhodium(I) and ruthenium(Ir) complexes were evaluated for their in vitro antifungal activity against Candida albicans. Four of the tested compounds, the rhodium containing compounds 30, 31, 32 and 33, were found effective at the minimum inhibitory concentrations(MICs) between 400-600 mu g/ml.eninfo:eu-repo/semantics/closedAccessantifungal drugsbenzimidazole derivatives, in vitro studiesbenzothiazole derivatives, in vitro studiescarbene-rhodium(I) complexes, in vitro studiescarbene-ruthenium(II) complexes, in vitro studiesAntifungal activity of organic and organometallic derivatives of benzimidazole and benzothiazoleArticle47566767092057842-s2.0-0030972257N/AWOS:A1997XD52900015Q3